These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34918107)

  • 1. Development of a Validated Stability-Indicating HPLC Method for Vinpocetine in the Presence of Potential Impurities in Tablet Dosage Form by Multiresponse Optimization.
    Karaer Ö; Dinç-Zor Ş; Aşçı B
    J AOAC Int; 2022 Apr; 105(3):688-695. PubMed ID: 34918107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of an RP-HPLC Method for the Determination of Vinpocetine and Folic Acid in the Presence of a Vinpocetine Alkaline Degradation Product in Bulk and in Capsule Form.
    Elkady EF; Tammam MH; Mohamed AA
    J AOAC Int; 2017 May; 100(3):671-676. PubMed ID: 28074742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS-Compatible Chromatographic Method for Quantification of Potential Organic Impurities of Elagolix Sodium in Tablet Dosage Form with Identification of Major Degradation Products.
    Desai P; Prajapati R; Chokshi A
    J AOAC Int; 2023 May; 106(3):568-579. PubMed ID: 36721330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.
    Mallavarapu R; Katari NK; Dongala T; Rekulapally VK; Marisetti VM; Vyas G
    Biomed Chromatogr; 2022 Jan; 36(1):e5247. PubMed ID: 34541698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A UPLC method development and validation study of Upadacitinib and its impurities in extended - release oral tablet dosage forms.
    Nimmagadda RL; Gummadi S
    Ann Pharm Fr; 2024 Sep; 82(5):780-791. PubMed ID: 38554818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method.
    Mantripragada MKVVN; Rao SV; Nutulapati VVS; Mantena BPV
    J Chromatogr Sci; 2018 Mar; 56(3):270-284. PubMed ID: 29300835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study.
    Chinta SR; Chintala V; Nandimalla V; Ch R; Ediga SG; Kowtharapu LP; Katari NK
    J AOAC Int; 2024 Jan; 107(1):31-39. PubMed ID: 37758265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated stability-indicating liquid chromatographic method for determination of degradation impurities and diastereomers in voriconazole tablets.
    Shaikh KA; Patil AT
    Sci Pharm; 2012; 80(4):879-88. PubMed ID: 23264937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability-indicating LC-UV method for the determination of eszopiclone and degradation impurities in tablet dosage form.
    Shaikh K; Patil A; Gite S
    J Chromatogr Sci; 2014 Apr; 52(4):293-7. PubMed ID: 23552846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Hydrophilic Interaction Liquid Chromatography Method for the Analysis of Moxonidine and Its Impurities.
    Filipic S; Elek M; Popović M; Nikolic K; Agbaba D
    J Anal Methods Chem; 2016; 2016():3715972. PubMed ID: 27847672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impurity profile of macitentan in tablet dosage form using a stability-indicating high performance liquid chromatography method and forced degradation study].
    Lakka NS; Kuppan C; Rangasamy P
    Se Pu; 2019 Jan; 37(1):100-110. PubMed ID: 30693716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Stability-Indicating RP-HPLC Method for Simultaneous Quantification of Diacerein and Aceclofenac in Novel Nanoemulgel Formulation and Commercial Tablet Dosage Form in the Presence of their Major Degradation Products Using DoE Approach.
    Kazi TM; Dandagi PM
    J Chromatogr Sci; 2023 Dec; 61(10):918-929. PubMed ID: 37194660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Box-Behnken Design-Desirability Function Approach in Optimization of HPLC Method for Simultaneous Determination of Ibuprofen Along with Additives in Syrup Formulation.
    Dinç-Zor Ş; Aksu Dönmez Ö
    J AOAC Int; 2021 Mar; 104(1):78-83. PubMed ID: 33751066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability Indicating Reverse Phase HPLC Method for Estimation of Rifampicin and Piperine in Pharmaceutical Dosage Form.
    Shah U; Patel S; Raval M
    Curr Drug Discov Technol; 2018; 15(1):54-64. PubMed ID: 28625149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability-indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach.
    Subramanian VB; Katari NK; Dongala T; Jonnalagadda SB
    Biomed Chromatogr; 2020 Jan; 34(1):e4719. PubMed ID: 31634417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a liquid chromatographic method for the simultaneous determination of aniracetam and its related substances in the bulk drug and a tablet formulation.
    Papandreou G; Zorpas K; Archontaki H
    J Pharm Biomed Anal; 2011 Nov; 56(3):615-22. PubMed ID: 21742456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-criteria decision making approach and experimental design as chemometric tools to optimize HPLC separation of domperidone and pantoprazole.
    Sivakumar T; Manavalan R; Muralidharan C; Valliappan K
    J Pharm Biomed Anal; 2007 Apr; 43(5):1842-8. PubMed ID: 17208403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.